每經訊，仁(ren)恒醫(yi)(yi)藥(yao)(yao)11月3日發(fa)布公(gong)(gong)告稱，根據公(gong)(gong)司(si)(si)發(fa)展戰略需要，公(gong)(gong)司(si)(si)全資(zi)(zi)(zi)子公(gong)(gong)司(si)(si)廣州仁(ren)恒制(zhi)藥(yao)(yao)有(you)限(xian)(xian)公(gong)(gong)司(si)(si)擬與海(hai)南(nan)中(zhong)旺醫(yi)(yi)療(liao)科技開發(fa)有(you)限(xian)(xian)公(gong)(gong)司(si)(si)共同出資(zi)(zi)(zi)設立海(hai)南(nan)愛(ai)眼醫(yi)(yi)藥(yao)(yao)有(you)限(xian)(xian)公(gong)(gong)司(si)(si)，注(zhu)(zhu)冊(ce)(ce)地為海(hai)南(nan)省海(hai)口(kou)市(shi)秀英區南(nan)海(hai)大道266號海(hai)口(kou)國家高新(xin)區創業孵化中(zhong)心(xin)負一樓C60室，注(zhu)(zhu)冊(ce)(ce)資(zi)(zi)(zi)本為人民(min)幣500萬元，其中(zhong)廣州仁(ren)恒制(zhi)藥(yao)(yao)有(you)限(xian)(xian)公(gong)(gong)司(si)(si)出資(zi)(zi)(zi)200萬元，占(zhan)注(zhu)(zhu)冊(ce)(ce)資(zi)(zi)(zi)本40%，海(hai)南(nan)中(zhong)旺醫(yi)(yi)療(liao)科技開發(fa)有(you)限(xian)(xian)公(gong)(gong)司(si)(si)出資(zi)(zi)(zi)300萬元，占(zhan)注(zhu)(zhu)冊(ce)(ce)資(zi)(zi)(zi)本60%。本次對外投資(zi)(zi)(zi)事項已經(jing)過(guo)公(gong)(gong)司(si)(si)第三屆董事會(hui)(hui)第二次會(hui)(hui)議審(shen)議通過(guo)，無需提交股東大會(hui)(hui)審(shen)議。

(記者 曾健輝)

免責聲明：本文內容與(yu)數據(ju)僅(jin)供(gong)參(can)考，不構成(cheng)投(tou)資建議，使用前(qian)請核實。據(ju)此操作，風險自(zi)擔。